Manipulation of oxygenation and flow-induced shear stress can increase the in vitro yield of platelets from cord blood
- PMID: 21877917
- DOI: 10.1089/ten.tec.2011.0108
Manipulation of oxygenation and flow-induced shear stress can increase the in vitro yield of platelets from cord blood
Abstract
A method to produce clinically useful platelets in vitro would help overcome the frequent shortages, donor deferrals, disease transmission, and alloimmunization with volunteer donor-derived platelets. Using CD34 positively selected cord blood cells, we investigated ways to increase platelet quality and yield in a three-dimensional modular perfusion bioreactor system. We found a two- to threefold increase in platelet numbers produced only when the early phases of the culture process were carried out at 5% oxygen, versus when 20% oxygen was used throughout the culture period (p<0.05), and much more than when 5% oxygen was used throughout. When the medium was routed through the cell-scaffold construct, versus when it flowed under and over the construct, or just intermittent feeding was used, the number of platelets increased two- to threefold (p<0.05), and enhanced collagen-induced aggregation. The 5% oxygen early in the culture process mimics the marrow adjacent to the bone where early progenitors proliferate. Flow through the cell-scaffold construct creates shear forces that mimic the flow in central venous sinuses of the marrow and enhances platelet production from proplatelets. The use of altered oxygen levels and cross flow enhanced platelet numbers and quality, and will contribute to eventual in vitro platelet production for clinical use.
Similar articles
-
Platelet bioreactor: accelerated evolution of design and manufacture.Platelets. 2017 Jul;28(5):472-477. doi: 10.1080/09537104.2016.1265922. Epub 2017 Jan 23. Platelets. 2017. PMID: 28112988 Free PMC article. Review.
-
Application of porous glycosaminoglycan-based scaffolds for expansion of human cord blood stem cells in perfusion culture.J Biomed Mater Res A. 2008 Jul;86(1):98-107. doi: 10.1002/jbm.a.31614. J Biomed Mater Res A. 2008. PMID: 17941019
-
[Formation of platelets from cord blood CD34+ cells-derived megakaryocytes induced by S-nitrosoglutathione].Sheng Li Xue Bao. 2006 Oct 25;58(5):490-3. Sheng Li Xue Bao. 2006. PMID: 17041735 Chinese.
-
[In vitro differentiation into megakaryocytes and generation of platelets from CD34+ cells of umbilical cord blood].Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Oct;31(5):776-81. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006. PMID: 17062951 Chinese.
-
Current status of platelet manufacturing in 3D or bioreactors.Biotechnol Prog. 2023 Sep-Oct;39(5):e3364. doi: 10.1002/btpr.3364. Epub 2023 Jun 9. Biotechnol Prog. 2023. PMID: 37294031 Review.
Cited by
-
Platelet bioreactor: accelerated evolution of design and manufacture.Platelets. 2017 Jul;28(5):472-477. doi: 10.1080/09537104.2016.1265922. Epub 2017 Jan 23. Platelets. 2017. PMID: 28112988 Free PMC article. Review.
-
Induction of differentiation of human stem cells ex vivo: Toward large-scale platelet production.World J Stem Cells. 2019 Sep 26;11(9):666-676. doi: 10.4252/wjsc.v11.i9.666. World J Stem Cells. 2019. PMID: 31616542 Free PMC article. Review.
-
Separation of in-vitro-derived megakaryocytes and platelets using spinning-membrane filtration.Biotechnol Bioeng. 2015 Apr;112(4):788-800. doi: 10.1002/bit.25477. Epub 2014 Nov 19. Biotechnol Bioeng. 2015. PMID: 25312394 Free PMC article.
-
Challenges and promises for the development of donor-independent platelet transfusions.Blood. 2013 Apr 25;121(17):3319-24. doi: 10.1182/blood-2012-09-455428. Epub 2013 Jan 15. Blood. 2013. PMID: 23321255 Free PMC article. Review.
-
Current status of blood 'pharming': megakaryoctye transfusions as a source of platelets.Curr Opin Hematol. 2017 Nov;24(6):565-571. doi: 10.1097/MOH.0000000000000378. Curr Opin Hematol. 2017. PMID: 28985194 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources